Carbon nanomaterial based biosensors for non-invasive detection of cancer and disease biomarkers for clinical diagnosis
The early diagnosis of diseases, eg, Parkinson's and Alzheimer's disease, diabetes, and
various types of cancer, and monitoring the response of patients to the therapy plays a …
various types of cancer, and monitoring the response of patients to the therapy plays a …
Applications of biosensors in Alzheimer's disease diagnosis
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive
and irreversible cognitive decline. Currently, it affects 36 million people and due to …
and irreversible cognitive decline. Currently, it affects 36 million people and due to …
Clinically accurate diagnosis of Alzheimer's disease via multiplexed sensing of core biomarkers in human plasma
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder, affecting one in
ten people aged over 65 years. Despite the severity of the disease, early diagnosis of AD is …
ten people aged over 65 years. Despite the severity of the disease, early diagnosis of AD is …
Chemical sensing platforms for detecting trace-level Alzheimer's core biomarkers
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and affects more
than 10% of the population aged over 65 worldwide. Despite considerable global efforts, AD …
than 10% of the population aged over 65 worldwide. Despite considerable global efforts, AD …
The roadmap of 2D materials and devices toward chips
A Liu, X Zhang, Z Liu, Y Li, X Peng, X Li, Y Qin, C Hu… - Nano-Micro Letters, 2024 - Springer
Due to the constraints imposed by physical effects and performance degradation, silicon-
based chip technology is facing certain limitations in sustaining the advancement of Moore's …
based chip technology is facing certain limitations in sustaining the advancement of Moore's …
Enhancing surface functionality of reduced graphene oxide biosensors by oxygen plasma treatment for Alzheimer's disease diagnosis
We performed oxygen plasma treatment on reduced graphene oxide (rGO) to improve its
surface reactivity with respect to biomolecular interactions. Oxygen-plasma-treated rGO …
surface reactivity with respect to biomolecular interactions. Oxygen-plasma-treated rGO …
Graphene-based enzyme-modified field-effect transistor biosensor for monitoring drug effects in Alzheimer's disease treatment
A reduced graphene oxide-based enzyme-modified field-effect transistor (RGO-EnFET) was
fabricated to study the enzymatic kinetics between acetylcholinesterase (AChE) and …
fabricated to study the enzymatic kinetics between acetylcholinesterase (AChE) and …
Recent advances and prospects in reduced graphene oxide-based photodetectors
Reduced graphene oxide (rGO) has tunable properties and acts as an efficient low-cost
alternative for graphene in many applications. It also has its own exciting electronic and …
alternative for graphene in many applications. It also has its own exciting electronic and …
Clinical detection of neurodegenerative blood biomarkers using graphene immunosensor
Accurate detection of blood biomarkers related to neurodegenerative diseases could
provide a shortcut to identifying early stage patients before the onset of symptoms. The …
provide a shortcut to identifying early stage patients before the onset of symptoms. The …
Recent progress in the graphene-based biosensing approaches for the detection of Alzheimer's biomarkers
Alzheimer's disease (AD) is one of the most common types of neurodegenerative disorders.
It is possible to identify AD early thanks to the measurement of specific biomarker levels …
It is possible to identify AD early thanks to the measurement of specific biomarker levels …